BlackRock Fund Advisors’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

BlackRock Fund Advisors’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$295K	Buy	56,718 +2,116	+4%	+$9.95K	﹤0.01%	3335
2016 Q3	$255K	Buy	54,602 +107	+0.2%	+$499	﹤0.01%	3372
2016 Q2	$215K	Sell	54,495 -856	-2%	-$3.2K	﹤0.01%	3424
2016 Q1	$172K	Sell	55,351 -4,036	-7%	-$13.5K	﹤0.01%	3523
2015 Q4	$271K	Buy	59,387 +3,007	+5%	+$14.3K	﹤0.01%	3418
2015 Q3	$266K	Sell	56,380 -1,488	-3%	-$9.61K	﹤0.01%	3376
2015 Q2	$414K	Sell	57,868 -561,477	-91%	-$4.22M	﹤0.01%	3262
2015 Q1	$5.25M	Buy	619,345 +1,646	+0.3%	+$14K	﹤0.01%	2818
2014 Q4	$5.75M	Buy	617,699 +84,448	+16%	+$734K	﹤0.01%	2798
2014 Q3	$4.44M	Sell	533,251 -30,346	-5%	-$281K	﹤0.01%	2824
2014 Q2	$6.51M	Buy	563,597 +17,438	+3%	+$179K	﹤0.01%	2682
2014 Q1	$6.92M	Buy	546,159 +166,647	+44%	+$2.15M	﹤0.01%	2618
2013 Q4	$4.11M	Sell	379,512 -15,010	-4%	-$174K	﹤0.01%	2938
2013 Q3	$4.88M	Buy	394,522 +41,987	+12%	+$581K	﹤0.01%	2826
2013 Q2	$4.71M	Buy	+352,535	New	+$4.53M	﹤0.01%	2727

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock Fund Advisors's DSCI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Derma Sciences, Inc. Common Stock (DE) (DSCI) stake by 3.9% in Q4 2016, buying an estimated $9.95K and bringing the position to 56,718 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #3335.

BlackRock Fund Advisors first reported a position in DSCI in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.92M in Q1 2014. 52 funds tracked by Wall St. Rank hold DSCI as of Q4 2016.

BlackRock Fund Advisors held 56,718 shares of Derma Sciences, Inc. Common Stock (DE) worth $295K as of Q4 2016.
BlackRock Fund Advisors bought 2,116 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2016, an estimated $9.95K.
Derma Sciences, Inc. Common Stock (DE) made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3335 holding.
BlackRock Fund Advisors first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and has held it in 15 quarters since.
BlackRock Fund Advisors's Derma Sciences, Inc. Common Stock (DE) position peaked at $6.92M in Q1 2014.
52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.